Abstract
This report analyzes the worldwide markets for Antibiotics in US$ Billion. The
Major product segments Analyzed are Penicillin, Cephalosporins, Macrolides,
Quinolones, Carbapenems, and Other Antibiotics (Aminoglycosides,
Tetracyclines, Sulfonamides, Mupirocin, Glycopeptides, Synercid, and
Oxazolidinones). The report provides separate comprehensive analytics for the
US, Canada, Japan, Europe, Asia Pacific, and Rest of World. Annual forecasts
are provided for each region for the period of 2000 through 2015. The report
profiles 204 companies including many key and niche players worldwide such as
Abbott Laboratories, MiddleBrook™ Pharmaceuticals, Inc., Bayer
HealthCare AG, Bristol-Myers Squibb Co., Cubist Pharmaceuticals, Inc., Daiichi
Sankyo Company, Limited, Eli Lilly and Co., GlaxoSmithKline Plc, Johnson &
Johnson, Kyorin Pharmaceutical Co., Ltd., LG Life Sciences Limited,
MiddleBrook™ Pharmaceuticals, Inc., Novartis AG, Pfizer Inc., Pliva
d.d., Roche, Sanofi-Aventis SA, Takeda Pharmaceutical Company, Ltd., Toyama
Chemical Co., Ltd., and Wyeth Pharmaceuticals, Inc. Market data and analytics
are derived from primary and secondary research. Company profiles are mostly
extracted from URL research and reported select online sources.
| 
View Cart
